GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » resTORbio Inc (NAS:TORC) » Definitions » Goodwill-to-Asset

resTORbio (resTORbio) Goodwill-to-Asset : 0.00 (As of Jun. 2020)


View and export this data going back to 2018. Start your Free Trial

What is resTORbio Goodwill-to-Asset?

Goodwill to Asset ratio measures how much goodwill a company is recording compared to the total level of its assets. resTORbio's Goodwill for the quarter that ended in Jun. 2020 was $0.00 Mil. resTORbio's Total Assets for the quarter that ended in Jun. 2020 was $74.34 Mil.


resTORbio Goodwill-to-Asset Historical Data

The historical data trend for resTORbio's Goodwill-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

resTORbio Goodwill-to-Asset Chart

resTORbio Annual Data
Trend Dec16 Dec17 Dec18 Dec19
Goodwill-to-Asset
- - - -

resTORbio Quarterly Data
Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20
Goodwill-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of resTORbio's Goodwill-to-Asset

For the Biotechnology subindustry, resTORbio's Goodwill-to-Asset, along with its competitors' market caps and Goodwill-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


resTORbio's Goodwill-to-Asset Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, resTORbio's Goodwill-to-Asset distribution charts can be found below:

* The bar in red indicates where resTORbio's Goodwill-to-Asset falls into.



resTORbio Goodwill-to-Asset Calculation

Goodwill to Asset ratio measures how much goodwill a company is recording compared to the total level of its assets.

It is calculated by dividing goodwill by total assets.

resTORbio's Goodwill to Asset Ratio for the fiscal year that ended in Dec. 2019 is calculated as

Goodwill to Asset (A: Dec. 2019 )=Goodwill/Total Assets
=0/93.912
=

resTORbio's Goodwill to Asset Ratio for the quarter that ended in Jun. 2020 is calculated as

Goodwill to Asset (Q: Jun. 2020 )=Goodwill/Total Assets
=0/74.342
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


resTORbio  (NAS:TORC) Goodwill-to-Asset Explanation

If the goodwill-to-asset ratio increases, it can mean that the company is recording a proportionately higher amount of goodwill, assuming total assets are remaining constant. It is generally good to see a company increasing its assets regularly; however, if these increases are coming from intangible assets, such as goodwill, the increases may not be as good.

Increases in the goodwill-to-asset ratio might suggest that a company has been aggressively acquiring other firms or has seen its tangible assets decrease in value. When a large portion of total assets are attributable to intangible assets (such as goodwill), the company may be at risk of having that portion of its asset base wiped out quickly if it must record any goodwill impairments. Decreases in the goodwill-to-assets ratio suggest that the company has either written down some goodwill or increased its tangible assets.

Asset needs vary from industry to industry. This is why comparing goodwill-to-assets ratios is generally most meaningful among companies within the same industry. By comparing a company's goodwill to assets ratio to those of other companies within the same industry, investors can get a feel for how a company is managing its goodwill.


resTORbio Goodwill-to-Asset Related Terms

Thank you for viewing the detailed overview of resTORbio's Goodwill-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


resTORbio (resTORbio) Business Description

Traded in Other Exchanges
N/A
Address
500 Boylston Street, 13th Floor, Boston, MA, USA, 02116
resTORbio Inc is a clinical-stage biopharmaceutical company. It mainly focuses on the development and commercialization of novel therapeutics for the treatment of aging-related diseases. The company focuses on the mechanistic target of rapamycin (mTOR) pathway which regulates aging, and specifically on selective inhibition of the target of rapamycin complex 1. It is also involved in the development of RTB101 which is a small molecule, potent TORC1 inhibitor. The company's pipeline products include RTB101 and RTB101+ everolimus.